ATP Bioluminescence for Rapid Environmental Monitoring in Non-Sterile Pharmaceutical Manufacturing: A Quality by...

Rapid and reliable environmental monitoring is critical in non-sterile pharmaceutical manufacturing to ensure contamination control and product quality. Conventional culture-based methods require extended incubation times and may delay decision-making. ATP bioluminescence has emerged as a rapid alternative; however, its implementation as a quantitative method requires appropriate validation in accordance with regulatory guidelines, particularly considering its limitation as a non-specific indicator of total biological residues rather than exclusively viable microorganisms.

To validate an ATP bioluminescence-based method as a rapid alternative to conventional culture-based techniques for environmental microbiological monitoring in non-sterile pharmaceutical manufacturing areas, in accordance with USP <1223> and a Quality by Design framework.

The method was evaluated using a pooled inoculum of Salmonella spp., Escherichia coli, Aspergillus brasiliensis, and Candida albicans, applying a commercial ATP bioluminescence system (Clean-Trace™) under controlled environmental surface conditions. Validation parameters included equivalence of results, linearity (R2 ≥ 0.9025), working range (1-500 CFU), precision (RSD), specificity, accuracy (recovery 75-125%), and limits of detection and quantification (<10 CFU). Statistical analyses included regression modeling and Bland-Altman agreement assessment (p > 0.05).

Results demonstrated strong quantitative agreement between ATP-derived signals (RLU) and CFU-based methods, supported by correlation coefficients (R2 ≥ 0.9025) and recovery values ranging from 90% to 114%. Bland-Altman analysis confirmed that differences between methods were within acceptable limits of agreement. A QbD-based robustness assessment evaluated the impact of sanitizing agents on the luciferin-luciferase reaction, identifying sodium hypochlorite and benzalkonium chloride as sources of transient signal interference, which stabilized after approximately 5 min. Cleaning procedures effectively removed both residual and microbial ATP from contaminated surfaces, achieving levels below 10 CFU and <15 RLU across multiple stainless steel types.

The ATP bioluminescence method met predefined USP <1223> validation acceptance criteria, including recovery (75-125%), statistical agreement (p > 0.05), and precision (RSD within acceptable limits), and demonstrated equivalence to conventional microbiological techniques. The method enables rapid and reliable detection of surface contamination, reducing analysis time from several days to seconds and supporting real-time decision-making in manufacturing environments.

This study presents a validated ATP bioluminescence method that enables real-time environmental monitoring in non-sterile pharmaceutical manufacturing, significantly reducing analysis time from days to seconds. The integration of a Quality by Design framework ensures method robustness under variable sanitization conditions. This approach supports improved contamination control, faster decision-making, and enhanced process efficiency in industrial settings.